跳至主要内容
临床试验/EUCTR2017-001451-30-NL
EUCTR2017-001451-30-NL进行中(未招募)1 期

Pharmacokinetics of a new paediatric formulation of valacyclovir used for prophylaxis and treatment of VZV and HSV infections in children, phase II (VALID II) - VALID-2

Radboud university medical center0 个研究点目标入组 16 人开始时间: 2019年5月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Subject is in the age of 1-12 years.
  • 2.Subject has an indication for (val)acyclovir prophylaxis and receives i.v. acyclovir.
  • 3.Subject is managed with a central venous catheter (CVC/Port-a-Cath).
  • 4.Subject’s parents have signed the Informed Consent Form prior to screening evaluations.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 16
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Severe anemia (Hb < 5.0 mmol/L).
  • 2.Full dose has not been taken.

研究者

相似试验